Financial Year |
March 31 2023 |
Monetary Funds |
431,806,775.63 |
Held-for-trading Financial Assets |
168,210,000.00 |
Notes Receivable |
16,220,529.70 |
Accounts Receivable |
2,125,325,795.12 |
Advances to Suppliers |
66,749,706.88 |
Other Receivables |
359,339,375.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
47,134,418.94 |
Inventories |
386,585,058.63 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
25,469,622.61 |
Total Current Assets |
8,818,958,815.99 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
2,639,359,056.94 |
Investment Properties |
-- |
Fixed Assetes |
639,535,296.31 |
Under-construction Projects |
779,176,939.61 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
780,941,032.27 |
R&D expenses |
222,088,069.43 |
Goodwill |
291,782,095.36 |
Long-Term Deferred and Prepaid Expenses |
11,183,364.62 |
Deferred Income Tax Assets |
184,324,954.54 |
Other Non-Current Assets |
150,424,064.66 |
Sub-Total of Non-Current Assets |
5,736,535,966.83 |
Total Assets |
14,555,494,782.82 |
Short-Term Loans |
1,820,052,341.20 |
Trading Financial liabilities |
-- |
Notes Payable |
174,332,876.11 |
Accounts Payable |
2,622,141,900.83 |
Accounts Received In Advance |
26,490.48 |
Employee Compensation Payable |
4,294,575.69 |
Taxes Payable |
5,300,052.98 |
Interest Payable |
-- |
Dividend Payable |
151,082,485.57 |
Other payables |
276,112,426.15 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
860,182,228.41 |
Other Current Liabilities |
2,314,246,848.11 |
Sub-Total of Current Liabilities |
8,170,052,816.75 |
Long-term Loans |
450,594,606.43 |
Bonds Payable |
517,340,277.79 |
Long-Term Accounts Payable |
444,287,598.78 |
Special Payable |
-- |
Estimatied Liabilities |
13,295,426.38 |
Deferred Income Tax Liabilities |
1,483,178.32 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,009,302,337.27 |
Total Liabilities |
10,179,355,154.02 |
Paid-In Capital(Or Share Stock) |
665,814,309.00 |
Capital Surplus |
1,964,644,118.30 |
Surplus Reserve |
164,994,677.73 |
LESS:Treasury Stock |
25,638,192.04 |
Undistributed Profits |
1,085,066,929.38 |
Minority Stockholder's Interest |
512,079,781.75 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,864,059,847.05 |
Owner's Equity(Stockholder's Equity) |
4,376,139,628.80 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
14,555,494,782.82 |